HomeCompareZBH vs EQT

ZBH vs EQT: Dividend Comparison 2026

ZBH yields 1.08% · EQT yields 1.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EQT wins by $4.56M in total portfolio value
10 years
ZBH
ZBH
● Live price
1.08%
Share price
$88.62
Annual div
$0.96
5Y div CAGR
0.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.2K
Annual income
$118.64
Full ZBH calculator →
EQT
EQT
● Live price
1.00%
Share price
$64.41
Annual div
$0.65
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.59M
Annual income
$3,847,685.36
Full EQT calculator →

Portfolio growth — ZBH vs EQT

📍 EQT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZBHEQT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZBH + EQT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZBH pays
EQT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZBH
Annual income on $10K today (after 15% tax)
$92.08/yr
After 10yr DRIP, annual income (after tax)
$100.84/yr
EQT
Annual income on $10K today (after 15% tax)
$85.12/yr
After 10yr DRIP, annual income (after tax)
$3,270,532.56/yr
At 15% tax rate, EQT beats the other by $3,270,431.71/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZBH + EQT for your $10,000?

ZBH: 50%EQT: 50%
100% EQT50/50100% ZBH
Portfolio after 10yr
$2.30M
Annual income
$1,923,902.00/yr
Blended yield
83.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQT right now

ZBH
Analyst Ratings
17
Buy
21
Hold
3
Sell
Consensus: Hold
Price Target
$105.60
+19.2% upside vs current
Range: $89.00 — $122.00
Altman Z
1.7
Piotroski
7/9
EQT
Analyst Ratings
29
Buy
15
Hold
Consensus: Buy
Price Target
$41.11
-36.2% upside vs current
Range: $23.00 — $55.00
Altman Z
2.3
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZBH buys
0
EQT buys
0
No recent congressional trades found for ZBH or EQT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZBHEQT
Forward yield1.08%1.00%
Annual dividend / share$0.96$0.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0.2%100%
Portfolio after 10y$21.2K$4.59M
Annual income after 10y$118.64$3,847,685.36
Total dividends collected$1.1K$4.50M
Payment frequencyquarterlyquarterly
SectorHealthcareEnergy
Analyst consensusHoldBuy
Analyst price target$105.60$41.11

Year-by-year: ZBH vs EQT ($10,000, DRIP)

YearZBH PortfolioZBH Income/yrEQT PortfolioEQT Income/yrGap
1← crossover$10,809$108.54$10,900$200.28$91.00EQT
2$11,675$109.86$12,071$408.06$396.00EQT
3$12,603$111.13$13,761$844.67$1.2KEQT
4$13,598$112.34$16,524$1,799.81$2.9KEQT
5$14,663$113.51$21,720$4,039.61$7.1KEQT
6$15,804$114.62$33,166$9,925.10$17.4KEQT
7$17,026$115.69$63,815$28,327.33$46.8KEQT
8$18,335$116.71$170,160$101,878.32$151.8KEQT
9$19,736$117.70$689,838$507,766.67$670.1KEQT
10$21,236$118.64$4,585,812$3,847,685.36$4.56MEQT

ZBH vs EQT: Complete Analysis 2026

ZBHHealthcare

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Full ZBH Calculator →

EQTEnergy

EQT Corporation operates as a natural gas production company in the United States. The company produces natural gas, natural gas liquids (NGLs), including ethane, propane, isobutane, butane, and natural gasoline. As of December 31, 2021, it had 25.0 trillion cubic feet of proved natural gas, NGLs, and crude oil reserves across approximately 2.0 million gross acres, including 1.7 million gross acres in the Marcellus play. The company was founded in 1878 and is headquartered in Pittsburgh, Pennsylvania.

Full EQT Calculator →
📬

Get this ZBH vs EQT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZBH vs SCHDZBH vs JEPIZBH vs OZBH vs KOZBH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.